Forward Pharma A Valuation
| FWPDelisted Stock | USD 2.56 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Forward Pharma A shows a prevailing Real Value of $1.77 per share. The current price of the firm is $2.56. Our model computes the value of Forward Pharma A from reviewing the firm fundamentals such as Number Of Shares Shorted of 4.51 K, current valuation of (43.04 M), and Shares Owned By Institutions of 12.90 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Forward Pharma's price fluctuation is very steady at this time. Calculation of the real value of Forward Pharma A is based on 3 months time horizon. Increasing Forward Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Forward Pharma's intrinsic value may or may not be the same as its current market price of 2.56, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.56 | Real 1.77 | Hype 2.56 | Naive 2.97 |
The intrinsic value of Forward Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Forward Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Forward Pharma A helps investors to forecast how Forward stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Forward Pharma more accurately as focusing exclusively on Forward Pharma's fundamentals will not take into account other important factors: Forward Pharma Total Value Analysis
Forward Pharma A is currently anticipated to have company total value of (43.04 M) with market capitalization of 13.83 M, debt of 0, and cash on hands of 70.77 M. The negative valuation of Forward Pharma may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the Forward Pharma fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(43.04 M) | 13.83 M | 0 | 70.77 M |
Forward Pharma Asset Utilization
One of the ways to look at asset utilization of Forward is to check how much profit was generated for every dollar of assets it reports. Forward Pharma A shows a negative utilization of assets of -0.0342 percent, losing $3.42E-4 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Forward Pharma A shows how discouraging it operates for each dollar spent on its assets.Forward Pharma Ownership Allocation
The market capitalization of Forward Pharma A is $13.83 Million. Roughly 87.1 percent of Forward Pharma outstanding shares are held by general public with 12.9 % by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Forward Pharma Profitability Analysis
Reported Net Loss for the year was (1.89 M) with profit before taxes, overhead, and interest of 0.About Forward Pharma Valuation
The delisted stock valuation mechanism determines Forward Pharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Forward Pharma A based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Forward Pharma. We calculate exposure to Forward Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Forward Pharma's related companies.Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma AS was incorporated in 2005 and is headquartered in Copenhagen, Denmark. Forward Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
Forward Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Forward Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 7 M | |
| Retained Earnings | -16.7 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Forward Stock
If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |